Infectious Agents and Cancer 期刊简介
Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.
The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular:
• HPV and anogenital cancers, as well as head and neck cancers;
• EBV and Burkitt lymphoma;
• HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases;
• HHV8 and Kaposi sarcoma;
• HTLV and leukemia;
• Cancers in Low- and Middle-income countries.
The link between infection and cancer has become well established over the past 50 years, and infection-associated cancer contribute up to 16% of cancers in developed countries and 33% in less developed countries.
Preventive vaccines have been developed for only two cancer-causing viruses, highlighting both the opportunity to prevent infection-associated cancers by vaccination and the gaps that remain before vaccines can be developed for other cancer-causing agents. These gaps are due to incomplete understanding of the basic biology, natural history, epidemiology of many of the pathogens that cause cancer, the mechanisms they exploit to cause cancer, and how to interrupt progression to cancer in human populations. Early diagnosis or identification of lesions at high risk of progression represent the current most critical research area of the field supported by recent advances in genomics and proteomics technologies.
传染病和癌症是一个开放获取,同行评审的在线期刊,涵盖了基础,临床,流行病学和转化研究提供了对慢性感染和癌症之间关联的洞察力。
该杂志欢迎在病原体相关癌症领域和其他相关主题的论文,特别是:
• HPV和肛门生殖器癌,以及头颈癌;
• EBV和伯基特淋巴瘤;
• HCV/HBV和肝细胞癌以及淋巴增生性疾病;
• HHV8和Kaposi肉瘤;
• HTLV和白血病;
• 低收入和中等收入国家的癌症。
在过去的50年中,感染与癌症之间的联系已经确立,与感染相关的癌症在发达国家占癌症的16%,在欠发达国家占33%。
仅针对两种致癌病毒开发了预防性疫苗,强调通过疫苗接种预防感染相关癌症的机会,以及在为其他致癌药物开发疫苗之前仍然存在的差距。这些差距是由于对导致癌症的许多病原体的基本生物学,自然历史,流行病学的不完全了解,它们利用的导致癌症的机制以及如何中断人类向癌症的发展。早期诊断或识别进展高风险的病变是该领域当前最关键的研究领域,得到了基因组学和蛋白质组学技术的最新进展的支持。
期刊ISSN
|
1750-9378 |
影响指数
|
2.935 |
最新CiteScore值
|
4.30 查看CiteScore评价数据 |
最新自引率
|
1.60% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW |
偏重的研究方向(学科)
|
ONCOLOGY-IMMUNOLOGY |
出版周期
|
|
出版年份
|
2006 |
出版国家/地区
|
ENGLAND |
是否OA
|
Yes |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
IMMUNOLOGY(免疫学)4区
ONCOLOGY(肿瘤学)4区
否
|
|||||
最新的影响因子
|
2.935 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 30 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
4.30
|
||||||||||||||||||||||
年文章数 | 68 | ||||||||||||||||||||||
SJR
|
0.774 | ||||||||||||||||||||||
SNIP
|
1.030 | ||||||||||||||||||||||
CiteScore排名
|
|
||||||||||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY | 2.026 |
AIDS | 4.135 |
APMIS | 3.173 |
VACCINE | 3.605 |
BIODRUGS | 5.749 |
IMMUNITY | 31.428 |
LYMPHOLOGY | 1.273 |
Lancet HIV | 12.639 |
AIDS REVIEWS | 2.475 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY | 2.026 |
VACCINE | 3.605 |
AIDS REVIEWS | 2.475 |
AUTOIMMUNITY | 2.787 |
TUBERCULOSIS | 3.1 |
IMMUNOBIOLOGY | 3.113 |
Immunotherapy | 4.154 |
BMC IMMUNOLOGY | 3.579 |
IMMUNOLOGY LETTERS | 3.648 |
分享者 | 点评内容 |